SynthesisFrontiers in immunology2026
Case Report: Small bowel metastasis from esophageal squamous cell carcinoma: a case series and systematic review of clinical characteristics, tropism, and survival outcomes.
Synthesis in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Small bowel metastasis from primary esophageal carcinoma is a rare occurrence, typically indicative of advanced disease and often presenting with non-specific abdominal symptoms. Failure to consider this possibility in the differential diagnosis may lead to delayed or incorrect management. This article reports the case of a 60-year-old male with small bowel metastasis originating from esophageal squamous cell carcinoma. To better characterize this clinical entity, we also conducted a systematic review of 23 documented cases, analyzing their clinicopathological features, diagnostic approaches, treatment modalities, and prognostic outcomes. Case presentation: A 60-year-old man presented with small bowel obstruction, ultimately diagnosed as metastatic esophageal squamous cell carcinoma. Surgical resection was followed by combined immunotherapy and chemotherapy, yielding a partial response. Systematic review: We reviewed 23 published cases, highlighting a strong male predominance (82.6%), jejunal predilection, and a median survival of only 6 months post-diagnosis. Small bowel metastasis from esophageal carcinoma, though uncommon, represents a challenging clinical scenario often mimicking more common abdominal pathologies. Histopathological confirmation is essential for accurate diagnosis. Early detection and a multidisciplinary treatment approach may correlate with favorable survival trends in these advanced-stage patients. Conclusions: Small bowel metastasis should be considered in esophageal cancer patients with acute abdominal symptoms. Histopathological confirmation is crucial, and a multimodal approach may be associated with extended survival trends in selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.